2018 American Transplant Congress
Impact of Pulsatile Perfusion Machine on Postoperative Outcomes in Standard Criteria Donor Kidney Transplants
1Hospital Geral de Fortaleza, Fortaleza, Brazil; 2Universidade Federal do Ceara, Fortaleza, Brazil.
Introduction: Delayed graft function (DGF) negatively impacts kidney transplant (KT) outcomes. Our aim was to assess the impact of pulsatile machine perfusion (MP) on KT…2018 American Transplant Congress
Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients
Background. Many immunosuppressive drugs are prescribed as twice-daily dosing. Simplified once-daily dosing of the entire drug regimen can improve treatment satisfaction for patients. We examined…2018 American Transplant Congress
Does One Size Fit All? Implementing a Protocolized Ambulatory Tacrolimus Dosing Strategy in a Predominantly African American Renal Transplant Population
Medical University of South Carolina, Charleston, SC.
Introduction: African American (AA) KTx recipients have significant tacrolimus (FK) inter patient variability making protocolized dosage adjustment challenging. We sought to evaluate the efficacy &…2018 American Transplant Congress
Evaluation of Tacrolimus Extended-Release in African American Renal Transplant Recipients
University of Maryland, Baltimore.
Purpose: Limited data exists to guide appropriate dosing strategies for novel tacrolimus formulations, such as tacrolimus XL (Astagraf XL). This is especially true in the…2018 American Transplant Congress
The Infusion with a Difference: Patient Experiences with Belatacept
Yale University, New Haven, CT.
Introduction: The results of the BENEFIT trial led to the FDA approval of the novel anti-rejection agent belatacept (bela) in 2011. In addition to its…2018 American Transplant Congress
Efficacy of Current Educational Interventions in Improving Living Donor Kidney Transplantation Rates
McGill Unversity Health Center, Montreal, Canada.
IntroductionLack of knowledge and discomfort approaching a donor are two of the most common recognized, recipient-level barriers to living donor kidney transplantation (LDKT). To address…2018 American Transplant Congress
How Old is Too Old? Expanding Living Kidney Organ Transplantation from Donors above 60 Years of Age with Associated Comorbidity.
Transplant Surgery, St Georges University Hospital NHS Foundation Trust, London, United Kingdom.
Background: Worldwide the population is ageing. In UK there are more people above 60 than under 16 years of age. Hence there are more elderly…2018 American Transplant Congress
Evaluation of Transplant Kidneys Using a Novel Point of Care 3D Ultrasound System
1Duke University, Durham, NC; 2Stanford University, Palo Alto, CA.
Purpose: The clinical utility of two-dimensional (2D) ultrasound (US) in the evaluation of renal transplant patients is limited by user dependence and restricted planar image…2018 American Transplant Congress
Artificial Graft Extension of Renal Vein in Living Kidney Transplantation
Background. The recovered kidney sometimes has a renal vein short in length for a satisfactory anastomosis or in some cases the vein can be damaged…2018 American Transplant Congress
Association between Donor/Recipient BK Viral Serostatus and Risk of BK Viraemia Post-Transplantation
IntroductionThe development of BK viraemia, and subsequently, BK nephropathy is a potentially devastating event associated with kidney transplant loss. In contrast to other clinically important…
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 211
- Next Page »